Education

Undergraduate School

Saint Joseph's College
1975 Philadelphia PA

Medical School

University of Pennsylvania School of Medicine
1979 Philadelphia PA

Internship

Children's Hospital of Philadelphia
1980 Philadelphia PA

Residency

Children's Hospital of Philadelphia
1982 Philadelphia PA

Fellowship

Cardiac Electrophysiology Boston Children's Hospital
1984 Boston MA

Fellowship

Cardiac Electrophysiology Massachusetts General Hospital
1985 Boston MA

Media

Caregiver Profile

Meet Dr. Edward Walsh

Publications

  1. A Natural History Study of Timothy Syndrome. Orphanet J Rare Dis. 2024 Nov 23; 19(1):433. View Abstract
  2. Intraoperative Conduction Mapping to Reduce Postoperative Atrioventricular Block in Complex Congenital Heart Disease. J Am Coll Cardiol. 2024 Nov 19; 84(21):2102-2112. View Abstract
  3. Ventricular septation for double inlet ventricle: Avoiding conduction injury. J Thorac Cardiovasc Surg. 2025 Apr; 169(4):1055-1065. View Abstract
  4. Efficacy and safety of early postoperative ablation in patients with congenital heart disease. Heart Rhythm. 2024 Sep 06. View Abstract
  5. Surgical debulking of large ventricular fibromas in children. J Thorac Cardiovasc Surg. 2025 Jan; 169(1):186-194. View Abstract
  6. A Natural History Study of Timothy Syndrome. medRxiv. 2024 May 21. View Abstract
  7. Medical cardioversion of atrial fibrillation and flutter with class IC antiarrhythmic drugs in young patients with and without congenital heart disease. J Cardiovasc Electrophysiol. 2023 12; 34(12):2545-2551. View Abstract
  8. Retroflexed catheter course reduces the risk of right free wall accessory pathway recurrence. J Cardiovasc Electrophysiol. 2023 09; 34(9):1828-1834. View Abstract
  9. Clinical implications of a unique delta wave pattern in patients with left-sided Wolff-Parkinson-White. Europace. 2023 05 19; 25(5). View Abstract
  10. Ablation within the coronary venous system in young patients: A focus on safety. Heart Rhythm. 2023 06; 20(6):900-901. View Abstract
  11. Clinical risk prediction score for postoperative accelerated junctional rhythm and junctional ectopic tachycardia in children with congenital heart disease. Heart Rhythm. 2023 07; 20(7):1011-1017. View Abstract
  12. Ventricular arrhythmias after fibroma resection: Are patients still at risk? Heart Rhythm. 2023 02; 20(2):243-249. View Abstract
  13. Radiofrequency Catheter Ablation for Pediatric Atrioventricular Nodal Reentrant Tachycardia: Impact of Age on Procedural Methods and Durable Success. J Am Heart Assoc. 2022 06 21; 11(12):e022799. View Abstract
  14. Catheter Ablation of Atrioventricular Nodal Reentrant Tachycardia in Patients With Congenital Heart Disease. Circ Arrhythm Electrophysiol. 2022 02; 15(2):e010631. View Abstract
  15. The Evolution of Pediatric and Congenital Electrophysiology as a Subspecialty. Pediatr Cardiol. 2022 Apr; 43(4):776-783. View Abstract
  16. Incessant atrial and ventricular tachycardias associated with an SCN5A mutation. HeartRhythm Case Rep. 2021 Dec; 7(12):806-811. View Abstract
  17. Accessory pathway ablation in Ebstein anomaly: A challenging substrate. Heart Rhythm. 2021 11; 18(11):1844-1851. View Abstract
  18. Conversations With Legends in Cardiac Electrophysiology. JACC Clin Electrophysiol. 2021 05; 7(5):684.e1-684.e8. View Abstract
  19. Lead age as a predictor for failure in pediatrics and congenital heart disease. Pacing Clin Electrophysiol. 2021 04; 44(4):586-594. View Abstract
  20. Risk Factors for Left Ventricular Dysfunction Following Surgical Management of Cardiac Fibroma. Circ Cardiovasc Imaging. 2021 02; 14(2):e011748. View Abstract
  21. Corrigendum to ' Ventricular Arrhythmia and Life-Threatening Events in Patients With Repaired Tetralogy of Fallot' [The American Journal of Cardiology 132 (2020) 126-132]. Am J Cardiol. 2021 Jan 01; 138:133. View Abstract
  22. Difference in the prevalence of intracardiac thrombus on the first presentation of atrial fibrillation versus flutter in the pediatric and congenital heart disease population. J Cardiovasc Electrophysiol. 2020 12; 31(12):3243-3250. View Abstract
  23. Risk Factors for Early Recurrence Following Ablation for Accessory Pathways: The Role of Consolidation Lesions. Circ Arrhythm Electrophysiol. 2020 11; 13(11):e008848. View Abstract
  24. Value of provocative electrophysiology testing in the management of pediatric patients after congenital heart surgery. Pacing Clin Electrophysiol. 2020 09; 43(9):901-907. View Abstract
  25. Ventricular Arrhythmia and Life-Threatening Events in Patients With Repaired Tetralogy of Fallot. Am J Cardiol. 2020 10 01; 132:126-132. View Abstract
  26. Adverse event rate during inpatient sotalol initiation for the management of supraventricular and ventricular tachycardia in the pediatric and young adult population. Heart Rhythm. 2020 06; 17(6):984-990. View Abstract
  27. Examination of pathologic features of the right atrioventricular groove in hearts with Ebstein anomaly and correlation with arrhythmias. Heart Rhythm. 2020 07; 17(7):1092-1098. View Abstract
  28. Outcomes of catheter ablation of anteroseptal and midseptal accessory pathways in pediatric patients. Heart Rhythm. 2020 05; 17(5 Pt A):759-767. View Abstract
  29. Arrhythmia Mechanisms and Outcomes of Ablation in Pediatric Patients With Congenital Heart Disease. Circ Arrhythm Electrophysiol. 2019 11; 12(11):e007663. View Abstract
  30. Long-term results of atrial maze surgery in patients with congenital heart disease. Europace. 2019 Sep 01; 21(9):1345-1352. View Abstract
  31. Interdigitating Myocardial Tongues in Pediatric Cardiac Fibromas: Plausible Substrate for Ventricular Tachycardia and Cardiac Arrest. JACC Clin Electrophysiol. 2019 05; 5(5):563-575. View Abstract
  32. Differentiation of fasciculoventricular fibers from anteroseptal accessory pathways using the surface electrocardiogram. Heart Rhythm. 2019 07; 16(7):1072-1079. View Abstract
  33. Dual-Site Ventricular Pacing in Patients With Fontan Physiology and Heart Block: Does it Mitigate the Detrimental Effects of Single-Site Ventricular Pacing? JACC Clin Electrophysiol. 2018 10; 4(10):1289-1297. View Abstract
  34. Evaluation of left ventricular false tendons in children with idiopathic left ventricular tachycardia. Pacing Clin Electrophysiol. 2018 09; 41(9):1143-1149. View Abstract
  35. Ebstein's Anomaly of the Tricuspid Valve: A Natural Laboratory for Re-Entrant Tachycardias. JACC Clin Electrophysiol. 2018 10; 4(10):1271-1288. View Abstract
  36. Catheter Ablation of Ventricular Arrhythmia for Ebstein's Anomaly in Unoperated and Post-Surgical Patients. JACC Clin Electrophysiol. 2018 10; 4(10):1300-1307. View Abstract
  37. Quality of life and social functioning of former long-stay psychiatric patients transferred into the community: a 10 year follow up study. Soc Psychiatry Psychiatr Epidemiol. 2018 Aug; 53(8):795-801. View Abstract
  38. Utility of incomplete right bundle branch block as an isolated ECG finding in children undergoing initial cardiac evaluation. Congenit Heart Dis. 2018 May; 13(3):419-427. View Abstract
  39. The role of ablation therapy for ventricular tachycardia in patients with tetralogy of Fallot. Heart Rhythm. 2018 05; 15(5):686-687. View Abstract
  40. Cardiac Events During Competitive, Recreational, and Daily Activities in Children and Adolescents With Long QT Syndrome. J Am Heart Assoc. 2017 Sep 21; 6(9). View Abstract
  41. Epicardial ablation of tachyarrhythmia in children: Experience at two academic centers. Pacing Clin Electrophysiol. 2017 Sep; 40(9):1017-1026. View Abstract
  42. The Phenotypic Spectrum of a Mutation Hotspot Responsible for the Short QT Syndrome. JACC Clin Electrophysiol. 2017 07; 3(7):727-743. View Abstract
  43. Improved understanding of ventricular Tachycardia in patients with tetralogy of Fallot. Eur Heart J. 2017 01 21; 38(4):277-279. View Abstract
  44. Improved understanding of ventricular tachycardia in patients with tetralogy of Fallot. Eur Heart J. 2016 Jun 05. View Abstract
  45. Catheter ablation for atrioventricular nodal reentrant tachycardia in patients with congenital heart disease. Heart Rhythm. 2016 06; 13(6):1228-37. View Abstract
  46. 2015 SPCTPD/ACC/AAP/AHA Training Guidelines for Pediatric Cardiology Fellowship Programs (Revision of the 2005 Training Guidelines for Pediatric Cardiology Fellowship Programs). J Am Coll Cardiol. 2015 Mar 13. View Abstract
  47. Task Force 4: Pediatric Cardiology Fellowship Training in Electrophysiology. J Am Coll Cardiol. 2015 Aug 11; 66(6):706-11. View Abstract
  48. Task Force 4: Pediatric Cardiology Fellowship Training in Electrophysiology. SPCTPD/ACC/AAP/AHA. Circulation. 2015 Aug 11; 132(6):e75-80. View Abstract
  49. Mechanism and ablation of arrhythmia following total cavopulmonary connection. Circ Arrhythm Electrophysiol. 2015 Apr; 8(2):318-25. View Abstract
  50. PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Can J Cardiol. 2014 Oct; 30(10):e1-e63. View Abstract
  51. Time dependence of risks and benefits in pediatric primary prevention implantable cardioverter-defibrillator therapy. Circ Arrhythm Electrophysiol. 2014 Dec; 7(6):1057-63. View Abstract
  52. Sudden death in adult congenital heart disease: risk stratification in 2014. Heart Rhythm. 2014 Oct; 11(10):1735-42. View Abstract
  53. PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: Executive Summary: Developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Heart Rhythm. 2014 Oct; 11(10):e81-e101. View Abstract
  54. PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Heart Rhythm. 2014 Oct; 11(10):e102-65. View Abstract
  55. Psychiatric functioning and quality of life in young patients with cardiac rhythm devices. Pediatrics. 2014 Apr; 133(4):e964-72. View Abstract
  56. Catheter ablation of Wolff-Parkinson-White syndrome in conjoined thoracopagus twins. Heart Rhythm. 2014 Jun; 11(6):1070-2. View Abstract
  57. Utility of preoperative electrophysiologic studies in patients with Ebstein's anomaly undergoing the Cone procedure. Heart Rhythm. 2014 Feb; 11(2):182-6. View Abstract
  58. Incidence of and risk factors for catheterization-induced complete heart block in the pediatric cardiac catheterization laboratory. Circ Arrhythm Electrophysiol. 2014 Feb; 7(1):127-33. View Abstract
  59. Successful surgical management of ventricular fibromas in children. J Thorac Cardiovasc Surg. 2014 Dec; 148(6):2602-8. View Abstract
  60. In-hospital arrhythmia development and outcomes in pediatric patients with acute myocarditis. Am J Cardiol. 2014 Feb 01; 113(3):535-40. View Abstract
  61. Update on interventional electrophysiology in congenital heart disease: evolving solutions for complex hearts. Circ Arrhythm Electrophysiol. 2013 Oct; 6(5):1032-40. View Abstract
  62. Hot topics in tetralogy of Fallot. J Am Coll Cardiol. 2013 Dec 10; 62(23):2155-66. View Abstract
  63. Transbaffle mapping and ablation for atrial tachycardias after mustard, senning, or Fontan operations. J Am Heart Assoc. 2013 Sep 19; 2(5):e000325. View Abstract
  64. Research accomplishments in pediatric electrophysiology: a historical review. Congenit Heart Dis. 2013 Sep-Oct; 8(5):362-9. View Abstract
  65. The role of cardiac resynchronization therapy for arterial switch operations complicated by complete heart block. Ann Thorac Surg. 2013 Sep; 96(3):904-9. View Abstract
  66. The use of an integrated electroanatomic mapping system and intracardiac echocardiography to reduce radiation exposure in children and young adults undergoing ablation of supraventricular tachycardia. Europace. 2014 Feb; 16(2):277-83. View Abstract
  67. Effect of aspirin and warfarin therapy on thromboembolic events in patients with univentricular hearts and Fontan palliation. Int J Cardiol. 2013 Oct 09; 168(4):3940-3. View Abstract
  68. The challenge of atrial tachycardia management in rheumatic heart disease. Pacing Clin Electrophysiol. 2013 Jul; 36(7):791-2. View Abstract
  69. Recommendations for advanced fellowship training in clinical pediatric and congenital electrophysiology: a report from the training and credentialing committee of the pediatric and congenital electrophysiology society. Heart Rhythm. 2013 May; 10(5):775-81. View Abstract
  70. The electrophysiological characteristics of accessory pathways in pediatric patients with intermittent preexcitation. Pacing Clin Electrophysiol. 2013 Sep; 36(9):1117-22. View Abstract
  71. Radiofrequency-assisted transseptal perforation for electrophysiology procedures in children and adults with repaired congenital heart disease. Pacing Clin Electrophysiol. 2013 May; 36(5):607-11. View Abstract
  72. WPW in conjoined thoracopagus twins. Heart Rhythm. 2014 Feb; 11(2):336-7. View Abstract
  73. Multiple accessory pathways in the young: the impact of structural heart disease. Am Heart J. 2013 Jan; 165(1):87-92. View Abstract
  74. Prospective evaluation of defibrillation threshold and postshock rhythm in young ICD recipients. Pacing Clin Electrophysiol. 2012 Dec; 35(12):1487-93. View Abstract
  75. Criminal offending before and after the onset of psychosis: examination of an offender typology. Schizophr Res. 2012 Sep; 140(1-3):198-203. View Abstract
  76. Variable QRS morphologies in Ebstein's anomaly: what is the mechanism? Heart Rhythm. 2013 Jun; 10(6):933-7. View Abstract
  77. Circulating matrix metalloproteinases in adolescents with hypertrophic cardiomyopathy and ventricular arrhythmia. Circ Heart Fail. 2012 Jul 01; 5(4):462-6. View Abstract
  78. Utility of serum procalcitonin values in patients with acute exacerbations of chronic obstructive pulmonary disease: a cautionary note. Int J Chron Obstruct Pulmon Dis. 2012; 7:127-35. View Abstract
  79. Cardiac tumors and associated arrhythmias in pediatric patients, with observations on surgical therapy for ventricular tachycardia. J Am Coll Cardiol. 2011 Oct 25; 58(18):1903-9. View Abstract
  80. Marked QT prolongation and ventricular tachycardia of a transient nature in young children with cardiomyopathy. Pacing Clin Electrophysiol. 2012 Aug; 35(8):e247-50. View Abstract
  81. The electroanatomic mechanisms of atrial tachycardia in patients with tetralogy of Fallot and double outlet right ventricle. J Cardiovasc Electrophysiol. 2011 Sep; 22(9):1013-7. View Abstract
  82. Marketing code of ethics for pediatric cardiology programs. Congenit Heart Dis. 2011 May-Jun; 6(3):209-10. View Abstract
  83. Nonfluoroscopic imaging systems reduce radiation exposure in children undergoing ablation of supraventricular tachycardia. Heart Rhythm. 2011 Apr; 8(4):519-25. View Abstract
  84. Sustained reduction in methicillin-resistant Staphylococcus aureus wound infections after cardiothoracic surgery. Arch Intern Med. 2011 Jan 10; 171(1):68-73. View Abstract
  85. Lead extraction in pediatric and congenital heart disease patients. Circ Arrhythm Electrophysiol. 2010 Oct; 3(5):437-44. View Abstract
  86. Epicardial left atrial appendage and biatrial appendage accessory pathways. Heart Rhythm. 2010 Dec; 7(12):1740-5. View Abstract
  87. A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus. Proc Natl Acad Sci U S A. 2010 May 11; 107(19):8800-5. View Abstract
  88. Atrial remodeling after the Fontan operation. Am J Cardiol. 2009 Dec 15; 104(12):1737-42. View Abstract
  89. System survival of nontransvenous implantable cardioverter-defibrillators compared to transvenous implantable cardioverter-defibrillators in pediatric and congenital heart disease patients. Heart Rhythm. 2010; 7(2):193-8. View Abstract
  90. Permanent atrial pacing lead implant route after Fontan operation. Pacing Clin Electrophysiol. 2009 Jun; 32(6):779-85. View Abstract
  91. Pulmonary valve replacement in tetralogy of Fallot: impact on survival and ventricular tachycardia. Circulation. 2009 Jan 27; 119(3):445-51. View Abstract
  92. Human metapneumovirus infections in adults: another piece of the puzzle. Arch Intern Med. 2008 Dec 08; 168(22):2489-96. View Abstract
  93. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008 Dec 02; 52(23):e143-e263. View Abstract
  94. ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines for the management of adults with congenital heart disease). Circulation. 2008 Dec 02; 118(23):2395-451. View Abstract
  95. ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Circulation. 2008 Dec 02; 118(23):e714-833. View Abstract
  96. Video-assisted thoracoscopic cardiac denervation: a potential novel therapeutic option for children with intractable ventricular arrhythmias. Ann Thorac Surg. 2008 Nov; 86(5):1620-5. View Abstract
  97. Ascending aortic dilation in patients with congenital complete heart block. Heart Rhythm. 2008 Dec; 5(12):1704-8. View Abstract
  98. Cardiac resynchronization therapy (and multisite pacing) in pediatrics and congenital heart disease: five years experience in a single institution. J Cardiovasc Electrophysiol. 2009 Jan; 20(1):58-65. View Abstract
  99. Cardiac conduction disturbances and ventricular tachycardia after prolonged propofol infusion in an infant. Pacing Clin Electrophysiol. 2008 Aug; 31(8):1070-3. View Abstract
  100. Ectopic atrial rhythm is a preablation predictor of atrioventricular nodal reentrant tachycardia in children. Pediatr Cardiol. 2008 Nov; 29(6):1066-70. View Abstract
  101. Atrioventricular nodal reentrant tachycardia with 2:1 block in pediatric patients. Heart Rhythm. 2008 Oct; 5(10):1391-5. View Abstract
  102. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol. 2008 Apr 29; 51(17):1685-91. View Abstract
  103. Digital music players cause interference with interrogation telemetry for pacemakers and implantable cardioverter-defibrillators without affecting device function. Heart Rhythm. 2008 Apr; 5(4):545-50. View Abstract
  104. How revealing are insertable loop recorders in pediatrics? Pacing Clin Electrophysiol. 2008 Mar; 31(3):338-43. View Abstract
  105. Practical aspects of implantable defibrillator therapy in patients with congenital heart disease. Pacing Clin Electrophysiol. 2008 Feb; 31 Suppl 1:S38-40. View Abstract
  106. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation. 2008 Jan 01; 117(1):85-92. View Abstract
  107. Impact of transvenous ventricular pacing leads on tricuspid regurgitation in pediatric and congenital heart disease patients. J Interv Card Electrophysiol. 2008 Jan; 21(1):65-8. View Abstract
  108. Interventional electrophysiology in patients with congenital heart disease. Circulation. 2007 Jun 26; 115(25):3224-34. View Abstract
  109. Influenza: evolving strategies in treatment and prevention. Semin Respir Crit Care Med. 2007 Apr; 28(2):144-58. View Abstract
  110. Arrhythmias in adult patients with congenital heart disease. Circulation. 2007 Jan 30; 115(4):534-45. View Abstract
  111. Serosurvey of human metapneumovirus infection in Croatia. Croat Med J. 2006 Dec; 47(6):878-81. View Abstract
  112. Ventricular size and function assessed by cardiac MRI predict major adverse clinical outcomes late after tetralogy of Fallot repair. Heart. 2008 Feb; 94(2):211-6. View Abstract
  113. Aggressive behaviour at first contact with services: findings from the AESOP First Episode Psychosis Study. Psychol Med. 2007 Apr; 37(4):547-57. View Abstract
  114. Cardiac conduction through engineered tissue. Am J Pathol. 2006 Jul; 169(1):72-85. View Abstract
  115. Age, size, and lead factors alone do not predict venous obstruction in children and young adults with transvenous lead systems. J Cardiovasc Electrophysiol. 2006 Jul; 17(7):754-9. View Abstract
  116. Transvenous pacing leads and systemic thromboemboli in patients with intracardiac shunts: a multicenter study. Circulation. 2006 May 23; 113(20):2391-7. View Abstract
  117. Ablation of nonautomatic focal atrial tachycardia in children and adults with congenital heart disease. J Cardiovasc Electrophysiol. 2006 Apr; 17(4):359-65. View Abstract
  118. Cryoablation for accessory pathways located near normal conduction tissues or within the coronary venous system in children and young adults. Heart Rhythm. 2006 Mar; 3(3):253-8. View Abstract
  119. A multicenter experience with novel implantable cardioverter defibrillator configurations in the pediatric and congenital heart disease population. J Cardiovasc Electrophysiol. 2006 Jan; 17(1):41-6. View Abstract
  120. Anesthetic management of the neonate with congenital complete heart block: a 16-year review. Paediatr Anaesth. 2005 Dec; 15(12):1059-66. View Abstract
  121. ACCF/AHA/AAP recommendations for training in pediatric cardiology. A report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence (ACC/AHA/AAP Writing Committee to Develop Training Recommendations for Pediatric Cardiology). Circulation. 2005 Oct 18; 112(16):2555-80. View Abstract
  122. ACC/AHA/AAP recommendations for training in pediatric cardiology. Pediatrics. 2005 Dec; 116(6):1574-96. View Abstract
  123. ACCF/AHA/AAP recommendations for training in pediatric cardiology. Task force 4: recommendations for training guidelines in pediatric cardiac electrophysiology endorsed by the Heart Rhythm Society. J Am Coll Cardiol. 2005 Oct 04; 46(7):1391-5. View Abstract
  124. First appropriate use of automated external defibrillator in an infant. Resuscitation. 2005 Oct; 67(1):135-7. View Abstract
  125. Comparison of modern steroid-eluting epicardial and thin transvenous pacemaker leads in pediatric and congenital heart disease patients. J Interv Card Electrophysiol. 2005 Oct; 14(1):27-36. View Abstract
  126. Prospective trial of electroanatomically guided, irrigated catheter ablation of atrial tachycardia in patients with congenital heart disease. Heart Rhythm. 2005 Jul; 2(7):700-5. View Abstract
  127. Utility of routine follow-up defibrillator threshold testing in congenital heart disease and pediatric populations. J Cardiovasc Electrophysiol. 2005 Jan; 16(1):69-73. View Abstract
  128. Radiofrequency catheter ablation of ventricular tachycardia in children and young adults with congenital heart disease. Heart Rhythm. 2004 Sep; 1(3):301-8. View Abstract
  129. Patient, procedural, and hardware factors associated with pacemaker lead failures in pediatrics and congenital heart disease. Heart Rhythm. 2004 Jul; 1(2):150-9. View Abstract
  130. Outcomes of radiofrequency catheter ablation of atrioventricular reciprocating tachycardia in patients with congenital heart disease. Heart Rhythm. 2004 Jul; 1(2):168-73. View Abstract
  131. Relation of right ventricular pacing in tetralogy of Fallot to electrical resynchronization. Am J Cardiol. 2004 Jun 01; 93(11):1449-52, A12. View Abstract
  132. Value of programmed ventricular stimulation after tetralogy of fallot repair: a multicenter study. Circulation. 2004 Apr 27; 109(16):1994-2000. View Abstract
  133. Recent advances in pacemaker and implantable defibrillator therapy for young patients. Curr Opin Cardiol. 2004 Mar; 19(2):91-6. View Abstract
  134. Psychosocial factors and quality of life in children and adolescents with implantable cardioverter-defibrillators. Am J Cardiol. 2004 Mar 01; 93(5):582-7. View Abstract
  135. Modification to the Fontan procedure for the prophylaxis of intra-atrial reentrant tachycardia: short-term results of a prospective randomized blinded trial. J Thorac Cardiovasc Surg. 2004 Mar; 127(3):721-9. View Abstract
  136. Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics. J Cardiovasc Electrophysiol. 2004 Jan; 15(1):72-6. View Abstract
  137. Radiofrequency catheter ablation of septal accessory pathways in the pediatric age group. Am J Cardiol. 2003 Oct 15; 92(8):947-50. View Abstract
  138. Efficacy of atrial antitachycardia pacing using the Medtronic AT500 pacemaker in patients with congenital heart disease. Am J Cardiol. 2003 Oct 01; 92(7):871-6. View Abstract
  139. Implantable cardioverter defibrillator lead complications and laser extraction in children and young adults with congenital heart disease: implications for implantation and management. J Cardiovasc Electrophysiol. 2003 Apr; 14(4):344-9. View Abstract
  140. Pericaval and periannular intra-atrial reentrant tachycardias in patients with congenital heart disease. J Cardiovasc Electrophysiol. 2003 Feb; 14(2):119-25. View Abstract
  141. Arrhythmias in patients with congenital heart disease. Card Electrophysiol Rev. 2002 Dec; 6(4):422-30. View Abstract
  142. Circadian and seasonal variation of malignant arrhythmias in a pediatric and congenital heart disease population. J Cardiovasc Electrophysiol. 2002 Oct; 13(10):1009-14. View Abstract
  143. Anticipatory use of venoarterial extracorporeal membrane oxygenation for a high-risk interventional cardiac procedure. Respir Care. 2002 Sep; 47(9):1002-6. View Abstract
  144. Prevalence of and risk factors for atrial fibrillation and intra-atrial reentrant tachycardia among patients with congenital heart disease. Am J Cardiol. 2002 Aug 01; 90(3):338-40. View Abstract
  145. Influence of patient factors and ablative technologies on outcomes of radiofrequency ablation of intra-atrial re-entrant tachycardia in patients with congenital heart disease. J Am Coll Cardiol. 2002 Jun 05; 39(11):1827-35. View Abstract
  146. NASPE Expert Consensus Conference: Radiofrequency catheter ablation in children with and without congenital heart disease. Report of the writing committee. North American Society of Pacing and Electrophysiology. Pacing Clin Electrophysiol. 2002 Jun; 25(6):1000-17. View Abstract
  147. Minimally invasive cardioverter defibrillator implantation for children: an animal model and pediatric case report. Pacing Clin Electrophysiol. 2001 Dec; 24(12):1789-94. View Abstract
  148. Spontaneously terminating apparent ventricular fibrillation during transesophageal electrophysiological testing in infants with Wolff-Parkinson-White syndrome. Pacing Clin Electrophysiol. 2001 Dec; 24(12):1816-8. View Abstract
  149. Postoperative ectopic atrial tachycardia in children with congenital heart disease. Am J Cardiol. 2001 Nov 15; 88(10):1169-72. View Abstract
  150. Supraventricular arrhythmias in children and young adults with implantable cardioverter defibrillators. J Cardiovasc Electrophysiol. 2001 Oct; 12(10):1097-101. View Abstract
  151. Atrioventricular reciprocating tachycardia involving twin atrioventricular nodes in patients with complex congenital heart disease. J Cardiovasc Electrophysiol. 2001 Jun; 12(6):671-9. View Abstract
  152. Paucity of sinus node dysfunction following repair of sinus venosus defects in children. Am J Cardiol. 2001 May 15; 87(10):1223-6; A8. View Abstract
  153. Multi atrial maco-re-entry circuits in adults with repaired congenital heart disease: entrainment mapping combined with three-dimensional electroanatomic mapping. J Am Coll Cardiol. 2001 May; 37(6):1665-76. View Abstract
  154. Electroanatomic mapping of entrained and exit zones in patients with repaired congenital heart disease and intra-atrial reentrant tachycardia. Circulation. 2001 Apr 24; 103(16):2060-5. View Abstract
  155. Long-term results of the lateral tunnel Fontan operation. J Thorac Cardiovasc Surg. 2001 Jan; 121(1):28-41. View Abstract
  156. Electroanatomic characterization of conduction barriers in sinus/atrially paced rhythm and association with intra-atrial reentrant tachycardia circuits following congenital heart disease surgery. J Cardiovasc Electrophysiol. 2001 Jan; 12(1):17-25. View Abstract
  157. Recombinant rinderpest vaccines expressing membrane-anchored proteins as genetic markers: evidence of exclusion of marker protein from the virus envelope. J Virol. 2000 Nov; 74(21):10165-75. View Abstract
  158. Location of acutely successful radiofrequency catheter ablation of intraatrial reentrant tachycardia in patients with congenital heart disease. Am J Cardiol. 2000 Nov 01; 86(9):969-74. View Abstract
  159. Estimation of atrial response to entrainment pacing using electrograms recorded from remote sites. J Cardiovasc Electrophysiol. 2000 Nov; 11(11):1215-22. View Abstract
  160. Cost-effectiveness and implications of newborn screening for prolongation of QT interval for the prevention of sudden infant death syndrome. J Pediatr. 2000 Apr; 136(4):481-9. View Abstract
  161. Development of a genetically marked recombinant rinderpest vaccine expressing green fluorescent protein. J Gen Virol. 2000 Mar; 81(Pt 3):709-18. View Abstract
  162. Psychological functioning in children and adolescents undergoing radiofrequency catheter ablation. Psychosomatics. 2000 Mar-Apr; 41(2):134-9. View Abstract
  163. Value of programmed ventricular stimulation in patients with congenital heart disease. J Cardiovasc Electrophysiol. 1999 Aug; 10(8):1033-44. View Abstract
  164. Characteristics, management, and midterm outcome in infants with atrioventricular nodal reentry tachycardia. Am J Cardiol. 1998 Oct 15; 82(8):956-60. View Abstract
  165. Duration of complete atrioventricular block after congenital heart disease surgery. Am J Cardiol. 1998 Aug 15; 82(4):525-7. View Abstract
  166. Long-term performance of bipolar epicardial atrial pacing using an active fixation bipolar endocardial lead. Pacing Clin Electrophysiol. 1998 May; 21(5):1098-104. View Abstract
  167. Five-year experience with radiofrequency catheter ablation: implications for management of arrhythmias in pediatric and young adult patients. J Pediatr. 1997 Dec; 131(6):878-87. View Abstract
  168. Left ventricular mechanics and geometry in patients with congenital complete atrioventricular block. Circulation. 1997 Nov 18; 96(10):3430-5. View Abstract
  169. Efficacy of radiofrequency ablation for control of intraatrial reentrant tachycardia in patients with congenital heart disease. J Am Coll Cardiol. 1997 Oct; 30(4):1032-8. View Abstract
  170. High-rate atrial pacing as an innovative bridging therapy in a neonate with congenital long QT syndrome. J Cardiovasc Electrophysiol. 1997 Jul; 8(7):812-7. View Abstract
  171. Spontaneous accelerated junctional rhythm: an unusual but useful observation prior to radiofrequency catheter ablation for atrioventricular node reentrant tachycardia in young patients. Pacing Clin Electrophysiol. 1997 Jun; 20(6):1654-61. View Abstract
  172. Syncope in the pediatric patient. Cardiol Clin. 1997 May; 15(2):277-94. View Abstract
  173. Predictors of permanence of successful radiofrequency lesions created with controlled catheter tip temperature. Pacing Clin Electrophysiol. 1997 May; 20(5 Pt 1):1283-91. View Abstract
  174. Evaluation of a staged treatment protocol for rapid automatic junctional tachycardia after operation for congenital heart disease. J Am Coll Cardiol. 1997 Apr; 29(5):1046-53. View Abstract
  175. Intra-atrial reentrant tachycardia after palliation of congenital heart disease: characterization of multiple macroreentrant circuits using fluoroscopically based three-dimensional endocardial mapping. J Cardiovasc Electrophysiol. 1997 Mar; 8(3):259-70. View Abstract
  176. Factors that influence the development of atrial flutter after the Fontan operation. J Thorac Cardiovasc Surg. 1997 Jan; 113(1):80-6. View Abstract
  177. Multipolar endocardial mapping of the right heart using a basket catheter: acute and chronic animal studies. Pacing Clin Electrophysiol. 1997 Jan; 20(1 Pt 1):51-9. View Abstract
  178. Novel missense mutation in the cyclic nucleotide-binding domain of HERG causes long QT syndrome. Am J Med Genet. 1996 Oct 02; 65(1):27-35. View Abstract
  179. Low-temperature mapping predicts site of successful ablation while minimizing myocardial damage. Circulation. 1996 Aug 01; 94(3):253-7. View Abstract
  180. Conversion of modified Fontan procedure to lateral atrial tunnel cavopulmonary anastomosis. J Thorac Cardiovasc Surg. 1996 Jun; 111(6):1169-76. View Abstract
  181. Missense mutation in the pore region of HERG causes familial long QT syndrome. Circulation. 1996 May 15; 93(10):1791-5. View Abstract
  182. Long-term outcome in patients with pacemakers following the Fontan operation. Am J Cardiol. 1996 Apr 15; 77(10):887-9. View Abstract
  183. Staged operation to Fontan increases the incidence of sinoatrial node dysfunction. J Thorac Cardiovasc Surg. 1996 Apr; 111(4):833-9; discussion 839-40. View Abstract
  184. Embolic complications associated with radiofrequency catheter ablation. Atakr Investigator Group. Am J Cardiol. 1996 Mar 15; 77(8):655-8. View Abstract
  185. Efficacy and risks of medical therapy for supraventricular tachycardia in neonates and infants. Am Heart J. 1996 Jan; 131(1):66-72. View Abstract
  186. Myocardial mechanics before and after ablation of chronic tachycardia. Pacing Clin Electrophysiol. 1996 Jan; 19(1):42-9. View Abstract
  187. High-density endocardial activation mapping of the right atrium in three dimensions by composition of multielectrode catheter recordings. J Electrocardiol. 1996; 29 Suppl:234-40. View Abstract
  188. Mechanisms and therapy of complex arrhythmias in pediatric patients. J Cardiovasc Electrophysiol. 1995 Dec; 6(12):1129-48. View Abstract
  189. Sotalol for refractory arrhythmias in pediatric and young adult patients: initial efficacy and long-term outcome. Am Heart J. 1995 Oct; 130(4):791-7. View Abstract
  190. Conversion of atrial flutter in pediatric patients by transesophageal atrial pacing: a safe, effective, minimally invasive procedure. Am Heart J. 1995 Aug; 130(2):323-7. View Abstract
  191. Use of adenosine-sensitive nondecremental accessory pathways in assessing the results of radiofrequency catheter ablation. Am J Cardiol. 1995 Jun 15; 75(17):1278-81. View Abstract
  192. Factors influencing impedance during radiofrequency ablation in humans. Chin Med J (Engl). 1995 Jun; 108(6):450-5. View Abstract
  193. Benefits and potential risks of atrial antitachycardia pacing after repair of congenital heart disease. Pacing Clin Electrophysiol. 1995 May; 18(5 Pt 1):1005-16. View Abstract
  194. Effects of propofol or isoflurane anesthesia on cardiac conduction in children undergoing radiofrequency catheter ablation for tachydysrhythmias. Anesthesiology. 1995 Apr; 82(4):884-7. View Abstract
  195. Radiofrequency ablation of intra-atrial reentrant tachycardia after surgical palliation of congenital heart disease. Circulation. 1995 Feb 01; 91(3):707-14. View Abstract
  196. Arrhythmias and intracardiac conduction after the arterial switch operation. J Thorac Cardiovasc Surg. 1995 Feb; 109(2):303-10. View Abstract
  197. Arrhythmias in children prenatally exposed to cocaine. Arch Pediatr Adolesc Med. 1994 Nov; 148(11):1163-9. View Abstract
  198. Efficacy and safety of radiofrequency ablation in infants and young children < 18 months of age. Am J Cardiol. 1994 Nov 01; 74(9):944-7. View Abstract
  199. Programmed atrial stimulation via the esophagus for management of supraventricular arrhythmias in infants and children. Am J Cardiol. 1994 Aug 15; 74(4):353-6. View Abstract
  200. Staged pacing therapy for congenital complete heart block in premature infants. Am J Cardiol. 1994 Aug 15; 74(4):412-3. View Abstract
  201. Late enlargement of radiofrequency lesions in infant lambs. Implications for ablation procedures in small children. Circulation. 1994 Jul; 90(1):492-9. View Abstract
  202. Radiofrequency catheter ablation for tachyarrhythmias in children and adolescents. The Pediatric Electrophysiology Society. N Engl J Med. 1994 May 26; 330(21):1481-7. View Abstract
  203. Multipolar endocardial mapping of the right atrium during cardiac catheterization: description of a new technique. J Am Coll Cardiol. 1993 Oct; 22(4):1105-10. View Abstract
  204. Radiofrequency ablation of accessory pathways associated with congenital heart disease including heterotaxy syndrome. Am J Cardiol. 1993 Sep 15; 72(9):689-93. View Abstract
  205. Catheter ablation of accessory atrioventricular pathways in young patients: use of long vascular sheaths, the transseptal approach and a retrograde left posterior parallel approach. J Am Coll Cardiol. 1993 Mar 01; 21(3):571-83. View Abstract
  206. Variable location of accessory pathways associated with the permanent form of junctional reciprocating tachycardia and confirmation with radiofrequency ablation. Am J Cardiol. 1992 Dec 15; 70(20):1559-64. View Abstract
  207. Transcatheter ablation of ectopic atrial tachycardia in young patients using radiofrequency current. Circulation. 1992 Oct; 86(4):1138-46. View Abstract
  208. Transcatheter ablation for pediatric tachyarrhythmias using radiofrequency electrical energy. Pediatr Ann. 1991 Jul; 20(7):386, 388-92. View Abstract
  209. Congenital complete heart block in patients without anatomic cardiac defects. Am Heart J. 1989 Dec; 118(6):1193-8. View Abstract
  210. Results of the arterial switch operation for transposition of the great arteries with ventricular septal defect. Surgical considerations and midterm follow-up data. Circulation. 1989 Dec; 80(6):1689-705. View Abstract
  211. Midterm results after the arterial switch operation for transposition of the great arteries with intact ventricular septum: clinical, hemodynamic, echocardiographic, and electrophysiologic data. Circulation. 1988 Jun; 77(6):1333-44. View Abstract
  212. Late results in patients with tetralogy of Fallot repaired during infancy. Circulation. 1988 May; 77(5):1062-7. View Abstract
  213. Cerebral embolism resulting from an intracardiac tumor in tuberous sclerosis. Pediatr Neurol. 1986 Mar-Apr; 2(2):108-10. View Abstract
  214. Electrocardiogram of the premature infant at 1 year of age. Pediatrics. 1986 Mar; 77(3):353-6. View Abstract

Contact Edward Walsh

Print Profile